Expression of inflammatory markers in a genetic rodent model of depression

Behavioural Brain Research

Volumn 281, Issue , 2015, Pages 348-357

  Strenn, Nina ^a   Suchankova, Petra ^a   Nilsson, Staffan ^b   Fischer, Christina ^c   Wegener, Gregers ^c,d   Mathé, Aleksander A ^e   Ekman, Agneta ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^c AARHUS UNIVERSITY   (Denmark)

^d NORTH WEST UNIVERSITY   (South Africa)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

C3; Central gene expression; Flinders sensitive line; Immune system; S100B

Indexed keywords

COMPLEMENT COMPONENT C3; LIPOPOLYSACCHARIDE; PROTEIN S100B; S100B PROTEIN, RAT;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN DEVELOPMENT; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; DISEASE MARKER; DISEASE MODEL; FLINDERS RESISTANT LINE RAT STRAIN; FLINDERS SENSITIVE LINE RAT STRAIN; FORCED SWIM TEST; GENE; GENE EXPRESSION; GENETIC MODEL; HIPPOCAMPUS; HYPOTHALAMUS; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFLAMMATION; INFLAMMATORY GENE; MALE; NERVE CELL PLASTICITY; NONHUMAN; PREFRONTAL CORTEX; PROTEIN EXPRESSION; RAT; RAT STRAIN; STRAIN DIFFERENCE; ANIMAL; BRAIN; GENETICS; IMMUNOLOGY; INBRED RAT STRAIN; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION;

AMYGDALA; ANIMALS; BRAIN; COMPLEMENT C3; CORPUS STRIATUM; DEPRESSION; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HYPOTHALAMUS; LIPOPOLYSACCHARIDES; MALE; PREFRONTAL CORTEX; RATS; RATS, INBRED STRAINS; REAL-TIME POLYMERASE CHAIN REACTION; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT;

EID: 84920915040     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.09.025     Document Type: Article

References (60)

1. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006, 27:24-31.
2. Dantzer R., Connor J.C.O., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008, 9.
3. Tuglu C., Kara S.H., Caliyurt O., Vardar E., Abay E. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology 2003, 170:429-433.
4. Owen B., Eccleston D., Ferrier I., Young A. Raised levels of plasma interleukin-1b in major and postviral depression. Acta Psychiatr Scand 2001, 103:226-228.
5. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009, 71:171-186.
6. Wegener G., Mathe A.A., Neumann I.D. Selectively bred rodents as models of depression and anxiety. Curr Top Behav Neurosci 2012.
7. Overstreet D.H., Russell R.W. Selective breeding for diisopropyl fluorophosphate-sensitivity: behavioural effects of cholinergic agonists and antagonists. Psychopharmacology 1982, 78:150-155.
8. Sitaram N., Nurnberger J.I.J., Gershion E.S., Gillin C. Cholinergic regulation of mood and REM sleep: potential model and marker of vulnerability to affective disorder. Am J Psychiatry 1982, 139:571-576.
9. Neumann I.D., Wegener G., Homberg J.R., Cohen H., Slattery D.A., et al. Animal models of depression and anxiety: what do they tell us about human condition?. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:1357-1375.
10. Cryan J.F., Markou A., Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 2002, 23:238-245.
11. Zhu C-B., Lindler K.M., Owens A.W., Daws L.C., Blakely R.D., et al. Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacology 2010, 35:2510-2520.
12. Friedman E.M., Irwin M.R., Overstreet D.H. Natural and cellular immune responses in Flinders sensitive and resistant line rats. Neuropsychopharmacology 1996, 15:314-322.
13. Irwin M., Smith T.L., Gillin J.C. Low natural killer cytotoxicity in major depression. Life Sci 1987, 41:2127-2133.
14. Caldwell C.L., Irwin M., Lohr J. Reduced natural killer cell cytotoxicity in depression but not in schizophrenia. Biol Psychiatry 1991, 30:1131-1138.
15. Djurić V., Overstreet D., Bienenstock J., Perdue M. Immediate hypersensitivity in the Flinders rat: further evidence for a possible link between susceptibility to allergies and depression. Brain Behav Immun 1995, 9:196-206.
16. Friedman E.M., Becker K.A., Overstreet D.H., Lawrence D.A. Reduced primary antibody responses in a genetic animal model of depression. Psychosom Med 2002, 64:267-273.
17. Ayensu W.K., Pucilowski O., Mason G.A., Overstreet D.H., Rezvani A.H., et al. Effects of chronic mild stress on serum complement activity, saccharin preference, and corticosterone levels in Flinders lines of rats. Physiol Behav 1995, 57:165-169.
18. Ayensu W.K., Rezvani a.H., Overstreet D.H., Pucilowski O., Janowsky D.S. Ethanol and complement hemolytic activity of selectively bred hypercholinergic rats. Alcohol Alcohol 1992, 27:47-54.
19. Carboni L., Becchi S., Piubelli C., Mallei A., Giambelli R., et al. Early-life stress and antidepressants modulate peripheral biomarkers in a gene-environment rat model of depression. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:1037-1048.
20. Drevets W.C., Price J.L., Furey M.L. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct 2008, 213:93-118.
21. Satta M., Jacobs R., Kaltsas G., Grossman A. Endotoxin induces interleukin-1beta and nitric oxide synthase mRNA in rat hypothalamus and pituitary. Neuroendocrinology 1998, 67:109-116.
22. Porsolt R., LePichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
23. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008, 3:1101-1108.
24. Braw Y., Malkesman O., Dagan M., Bercovich A., Lavi-Avnon Y., et al. Anxiety-like behaviors in pre-pubertal rats of the Flinders Sensitive Line (FSL) and Wistar-Kyoto (WKY) animal models of depression. Behav Brain Res 2006, 167:261-269.
25. Overstreet D.H. Selective breeding for increased cholinergic function: development of a new animal model of depression. Biol Psychiatry 1986, 21:49-58.
26. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res 1996, 711:163-174.
27. Fu X., Zunich S.M., O'Connor J.C., Kavelaars A., Dantzer R., et al. Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures. J Neuroinflamm 2010, 7:43.
28. Deak T., Bellamy C., D'Agostino L.G., Rosanoff M., McElderry N.K., et al. Behavioral responses during the forced swim test are not affected by anti-inflammatory agents or acute illness induced by lipopolysaccharide. Behav Brain Res 2005, 160:125-134.
29. Donato R., Sorci G., Riuzzi F., Arcuri C., Bianchi R., et al. S100B's double life: intracellular regulator and extracellular signal. Biochim Biophys Acta 2009, 1793:1008-1022.
30. Li Y., Barger S.W., Liu L., Mrak R.E., Griffin W.S.T. S100beta induction of the proinflammatory cytokine interleukin-6 in neurons. J Neurochem 2000, 74:143-150.
31. Rothermundt M., Peters M., Prehn J.H.M., Arolt V. S100B in brain damage and neurodegeneration. Microsc Res Tech 2003, 60:614-632.
32. Adami C., Sorci G., Blasi E., Agneletti A.L., Bistoni F., et al. S100B expression in and effects on microglia. Glia 2001, 33:131-142.
33. Bianchi R., Kastrisianaki E., Giambanco I., Donato R. S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release. J Biol Chem 2011, 286:7214-7226.
34. Luo K.-R., Hong C.-J., Liou Y.-J., Hou S.-J., Huang Y.-H., et al. Differential regulation of neurotrophin S100B and BDNF in two rat models of depression. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:1433-1439.
35. Shapiro L.A., Bialowas-McGoey L.A., Whitaker-Azmitia P.M. Effects of S100B on serotonergic plasticity and neuroinflammation in the hippocampus in down syndrome and Alzheimer's Disease: studies in an S100B overexpressing mouse model. Cardiovasc Nsychiatry Neurol 2010.
36. Falcone T., Fazio V., Lee C., Simon B., Franco K., et al. Serum S100B: a potential biomarker for suicidality in adolescents?. PLoS One 2010, 5:e11089.
37. Kim J.-K., Kim S.G., Kim H.J., Song Y.R. Serum S100B protein is associated with depressive symptoms in patients with end-stage renal disease. Clin Biochem 2012.
38. Uher T., Bob P. Cerebrospinal fluid S100B levels reflect symptoms of depression in patients with non-inflammatory neurological disorders. Neurosci Lett 2012, 529:139-143.
39. Grabe H.J., Ahrens N., Rose H., Kessler C., Freyberger H.J. Neurotrophic factor S100beta in major depression. Neuropsychobiology 2001, 44:88-90.
40. Rothermundt M., Arolt V., Wiesmann M., Missler U., Peters M., et al. S-100B is increased in melancholic but not in non-melancholic major depression. J Affect Disord 2001, 66:89-93.
41. Rothermundt M., Falkai P., Ponath G., Abel S., Bürkle H., et al. Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF. Mol Psychiatry 2004, 9:897-899.
42. Suchankova P., Baghaei F., Rosmond R., Holm G., Anckarsäter H., et al. Genetic variability within the S100B gene influences the personality trait self-directedness. Psychoneuroendocrinology 2011, 36:919-923.
43. Urigüen L., Arteta D., Díez-Alarcia R., Ferrer-Alcón M., Díaz A., et al. Gene expression patterns in brain cortex of three different animal models of depression. Genes Brain Behav 2008, 7:649-658.
44. Stevens B., Allen N.J., Vazquez L.E., Howell G.R., Christopherson K.S., et al. The classical complement cascade mediates CNS synapse elimination. Cell 2007, 131:1164-1178.
45. Schafer D.P., Lehrman E.K., Kautzman A.G., Koyama R., Mardinly A.R., et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 2012, 74:691-705.
46. Chen F., Madsen T.M., Wegener G., Nyengaard J.R. Imipramine treatment increases the number of hippocampal synapses and neurons in a genetic animal model of depression. Hippocampus 2010, 20:1376-1384.
47. Boyle S.H., Jackson W.G., Suarez E.C. Hostility, anger, and depression predict increases in C3 over a 10-year period. Brain Behav Immun 2007, 21:816-823.
48. Berk M., Wadee A.A., Kuschket R.H. Acute phase proteins in major depression. J Psychosom Res 1997, 43:529-534.
49. Ditzen C., Tang N., Jastorff A.M., Teplytska L., Yassouridis A., et al. Cerebrospinal fluid biomarkers for major depression confirm relevance of associated pathophysiology. Neuropsychopharmacology 2012, 37:1013-1025.
50. Deak T., Bellamy C., D'Agostino L.G. Exposure to forced swim stress does not alter central production of IL-1. Brain Res 2003, 972:53-63.
51. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007, 462:453-462.
52. Maes M., Yirmiya R., Noraberg J., Brene S., Hibbeln J., et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 2009, 24:27-53.
53. Welser-Alves J.V., Crocker S.J., Milner R. A dual role for microglia in promoting tissue inhibitor of metalloproteinase (TIMP) expression in glial cells in response to neuroinflammatory stimuli. J Neuroinflamm 2011, 8:61.
54. Blaveri E., Kelly F., Mallei A., Harris K., Taylor A., et al. Expression profiling of a genetic animal model of depression reveals novel molecular pathways underlying depressive-like behaviours. PLoS One 2010, 5.
55. Shelton R.C., Sanders-Bush E., Manier D.H., Lewis D.A. Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A. Neuroscience 2009, 158:1406-1415.
56. Meyer J.H., McMain S., Kennedy S.H., Korman L., Brown G.M., et al. Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm. Am J Psychiatry 2003, 160:90-99.
57. Pelletier M., Siegel R.M. Wishing away inflammation? New links between serotonin and TNF signaling. Mol Interv 2009, 9:299-301.
58. Harbuz M.S., Perveen-Gill Z., Lalies M.D., Jessop D.S., Lightman S.L., et al. The role of endogenous serotonin in adjuvant-induced arthritis in the rat. Br J Rheumatol 1996, 35:112-116.
59. Yu B., Becnel J., Zerfaoui M., Rohatgi R., Boulares A.H., et al. Serotonin 5-hydroxytryptamine 2A receptor activation suppresses tumor necrosis factor-alpha-induced inflammation with extraordinary potency. J Pharmacol Exp Ther 2008, 327:316-323.
60. Bay-Richter C., Janelidze S., Hallberg L., Brundin L. Changes in behaviour and cytokine expression upon a peripheral immune challenge. Behav Brain Res 2011, 222:193-199.